期刊文献+

男性高血压患者的血压控制现状及影响因素分析 被引量:2

Blood pressure control situation and influential factors of male hypertension patients
下载PDF
导出
摘要 目的分析男性高血压患者的血压控制情况及影响因素。方法回顾性分析男性高血压患者2 159例,记录年龄、血压水平、早发心血管病家族史、体质量指数、吸烟史、血生化指标、相关靶器官损害及并存疾病等。所有患者均进行了超声心动图检查评价心脏的结构和功能。结果2 159例男性高血压患者服药率和血压控制率分别为92.3%、32.9%。降压药物中应用较多的是利尿剂、钙离子拮抗剂、血管紧张素受体拮抗剂和血管紧张素转换酶抑制剂。1 716例(79.5%)合并有高血压家族史、吸烟史、血脂异常、糖尿病史等危险因素。合并高血压家族史、动脉硬化的客观证据及脑卒中病史的患者血压不容易控制;冠心病患者的血压相对控制较好;高胆固醇血症、高甘油三酯血症患者血压控制较差;超声心动图检查左心室舒张末径、室间隔肥厚、左心室射血分数降低与血压控制不良相关。结论男性高血压患者的服药率较高,血压控制率较低,血压的控制并未有随着服药数量的增加而改善,与合并的危险因素及临床情况、生化指标及心脏的结构和功能有关。 [ Objective] To analyze blood pressure control situation and other influential factors of male hypertension patients. [ Methods] Retrospectively analyzed 2 159 male hypertension patients and recorded age, blood pressure, family medical history, body mass index, smoking history and so on. Echocardiography examination was undertaken to appraise cardiac structure and function. [ Results] The rate of treatment and blood pressure control was 92. 3% and 32. 9% respectively. Diuretic, calcium antagon, angiotensin receptor antagonist and converting enzyme inhibitor were commonly used. 1 716 (79.5%) patients merged with risk factors of family hypertension history, smoking , blood fat abnormality and diabetes. Among the concomitance disease and risk factors, there were significant difference of family history, arteriosclerotic evidence , stroke history , coronary artery disease, hypercholesterolemia, abnormal LVEDD, IVS and LVEF between two groups with normal and abnormal hypertention. [ Conclusion] Male hypertension patients have high treatment rate and low blood pressure control rate. The control situation associates with risk factors , clinical disease and cardiac structure and function.
出处 《山东医药》 CAS 北大核心 2007年第19期19-21,共3页 Shandong Medical Journal
关键词 男性 高血压 控制现状 影响因素 超声心动图 male hypertension control situation influential factor echocardiography
  • 相关文献

参考文献6

二级参考文献10

  • 1[1]Remme W J, Swedberg K. European society of cardio-logy. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the european society of cardiology. Eur J Heart Fail, 2002,4:11-22.
  • 2[2]Leslie C W, Talmadge E K, Marvin I S,et al. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis, 1986,133:97-103.
  • 3[3]Venugopal J. Cardiac natriuretic peptide-hope or hype? J Clin Pharmacol Ther,2001,26:15-31.
  • 4[4]Clerico A, Lervasi G, Mariani G. Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormaones in Humans.Horm Metab Res,1999,31:487-498.
  • 5[5]Hystad M E, Geiran O R, Attramadal H, et al. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol Scand, 2001,171:395-403.
  • 6[6]Sagnella G A. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci, 1998, 95:519-529.
  • 7[7]Maisel A S, Koon J, Krishnaswamy P,et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left vontricular dysfunction. Am Hear J, 2001,141:367-374.
  • 8F Javier Nieto.Cardiovascular disease and risk factor epidemiology:a look back at the epidemic of the 20th century[J].Am J Epidemiology,1999,89:292-293.
  • 9Wenchi Liang,Mona C Shediac Rizkallah,David D Celentano,et al.A population based study of age and gender difference in patterns of health related behaviors[J].Am J Prev Med,1999,17:8-17.
  • 10焦淑芳,尹香君,王瑜,谢瑾,郭飚.北京城区居民慢性病行为危险因素分析及对策研究[J].中国公共卫生,2002,18(2):197-198. 被引量:23

共引文献2666

同被引文献23

引证文献2

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部